Re-conceptualizing Parkinson’s disease as a lifelong neurobiological trajectory: A framework for prevention

A review in Neuroprotection (2026) reconceptualizes Parkinson’s disease as a lifelong neurobiological process shaped by early-life vulnerability, cumulative environmental exposures, and resilience factors. The authors integrate developmental biology, epigenetics, neuroimmune mechanisms, and brain plasticity into a prevention-focused framework. They highlight how early risks and lifelong protective behaviors influence disease trajectory, while emphasizing the need for longitudinal studies, early biomarkers, and targeted interventions to enable prevention rather than late-stage treatment.

A new review made available online on February 25, 2026, and published in Volume 4, Issue 1 of Neuroprotection journal on March 01, 2026, proposes a shift in how Parkinson’s disease (PD) is understood—not simply as a disorder of later life, but as the outcome of a lifelong neurobiological trajectory shaped by early vulnerability, cumulative exposures, and resilience-building factors across the lifespan. In Re-conceptualizing Parkinson’s disease as a lifelong neurobiological trajectory: A framework for prevention, Dr. Ayodeji Johnson Ajibare (Department of Physiology, Faculty of Basic Medical and Health Sciences, College of Medicine, Lead City University, Nigeria) and colleagues, present a prevention-focused framework that links developmental neurobiology, epigenetic programming, neuroimmune mechanisms, and brain plasticity to the long-term risk of PD.

Core findings

The study’s central purpose was to synthesize current evidence and propose a broader conceptual framework for understanding PD risk. Rather than treating PD only as a late-onset neurodegenerative condition, the review argues that susceptibility may begin much earlier in life through interactions between biology and environment. The paper examines how early-life stress, nutritional deficiency, and exposure to environmental toxicants may contribute to later dopaminergic vulnerability through mechanisms such as epigenetic alteration, neuroinflammatory priming, and mitochondrial dysfunction.

The review also highlights the other side of the trajectory: resilience. It discusses how lifelong physical activity, cognitive stimulation, nutritious diets, and enriched environments may promote neuroplasticity, strengthen neurobiological reserve, and reduce the cumulative burden of processes linked to PD. Importantly, the paper does not present this life-course model as a settled fact, but as a testable framework grounded in epidemiologic, experimental, and mechanistic evidence. The authors emphasize that current human evidence is still incomplete and, in some areas, contradictory, making this an important hypothesis-generating model for future work.

Innovation

The novelty of this review lies in its integration of developmental and adult-life perspectives into a single PD prevention framework. Existing discussions of PD often focus on genetics, adult environmental exposures, or symptom management after diagnosis. This review instead proposes that the disease should be understood across the full lifespan, with particular attention to sensitive developmental windows and to the continuing capacity of the brain for plastic adaptation in later life.

Another innovative aspect is the paper’s effort to bridge basic mechanistic science with clinical and public health thinking. It connects molecular processes such as DNA methylation, histone modification, neuroimmune activity, and mitochondrial impairment with practical prevention ideas, including early risk identification, long-term lifestyle interventions, and biomarker development. By bringing these strands together, the paper moves beyond a purely descriptive review and advances a new way of organizing PD research around prevention rather than only treatment.

Future directions

The review identifies several urgent next steps. First, there is a need for large intergenerational longitudinal studies that can track early-life exposures, biological markers, and later neurological outcomes with much greater precision. Second, more work is needed to develop biomarkers that can detect early mechanistic deviations long before the onset of clinical PD. Third, future intervention studies should move toward targeted prevention strategies that test whether maladaptive biological programming can be modified or resilience-enhanced across the lifespan.

The authors also note major unanswered questions. Critical developmental windows remain poorly defined. Gene–environment interactions are complex and not yet sufficiently mapped. Ethical and practical challenges also surround any attempt to intervene early in life based on future neurodegenerative risk. These gaps do not weaken the framework. Rather, they define the frontier for the next generation of PD research.

Broader impact

This work has implications beyond a theoretical reclassification of Parkinson’s disease. It pushes the field toward a more preventive model of neurological health, one that may influence research priorities, clinical thinking, and public health strategy. If PD risk is shaped across the lifespan, then prevention may need to begin well before motor symptoms appear and perhaps long before traditional neurology would usually intervene.

The broader value of this review is that it encourages scientists and clinicians to think in terms of cumulative vulnerability and cumulative resilience. It suggests that supporting maternal health, reducing toxic exposures, improving nutrition, promoting lifelong exercise, and strengthening cognitive engagement may all have relevance within a more complete PD prevention agenda. In that sense, the paper offers not only a new framework for PD, but also a wider model for thinking about chronic neurodegenerative disorders through the lens of lifelong brain health.